Intrathecal baclofen for spasticity management: a comparative analysis of spasticity of spinal vs cortical origin.
OBJECTIVE
To examine the differences in intrathecal baclofen management of individuals with spasticity of cortical vs spinal etiologies.


METHODS
Retrospective chart review of 57 individuals with the diagnoses of severe cortical and spinal spasticity requiring an intrathecal baclofen pump.


METHODS
Parameters evaluated included daily dosage of medication required, flex vs simple continuous delivery modes, dosing changes, need for other local spasticity treatment, and catheter complications.


RESULTS
There were no statistically significant differences between individuals with cortical spasticity and spinal spasticity when comparing daily dosage, number of contacts, and mode of delivery. At 6 months, there was a statistically significant difference in dosing between individuals with multiple sclerosis and those without. Within groups, there was a significant difference in average daily dosing over 3 years. A significant difference was found comparing the use of botulinum toxin type A for upper extremity spasticity within the cortical group. Nine individuals had catheter complications.


CONCLUSIONS
Cortical and spinal spasticity appear to parallel each other with no significant differences in daily dosing, dosing changes, and mode of delivery of intrathecal baclofen. This did not hold true at all time points for the multiple sclerosis subgroup. The significant difference noted within groups for daily dosing over the first 3 years challenges the notion of stable dosing over time. Focal injections of Botox/phenol in the upper extremities are an important adjunct therapy for patients with cortical spasticity, even after the placement of an intrathecal baclofen pump. Our complication rate was slightly lower than that reported in the literature.
Saval
April
A
SCI Program, Department of Physical Medicine and Rehabilitation, University of Michigan Medical Center, 325 E. Eisenhower Parkway, Ann Arbor, MI 48108. USA.
Chiodo
Anthony E
AE
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001418:Baclofen / Q000008:administration & dosage*; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D001930:Brain Injuries / Q000150:complications* / Q000473:pathology; D002540:Cerebral Cortex / Q000503:physiopathology*; D016009:Chi-Square Distribution; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007260:Infusion Pumps; D007278:Injections, Spinal / Q000379:methods; D008297:Male; D008875:Middle Aged; D009125:Muscle Relaxants, Central / Q000008:administration & dosage*; D009128:Muscle Spasticity / Q000188:drug therapy* / Q000209:etiology*; D009460:Neurologic Examination; D009465:Neuromuscular Agents / Q000627:therapeutic use; D012189:Retrospective Studies; D013119:Spinal Cord Injuries / Q000150:complications*; D013997:Time Factors; D055815:Young Adult
D009125:Muscle Relaxants, Central; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A; D001418:Baclofen
Top Stroke Rehabil. 2001 Spring;8(1):36-46
14523750
Clin Neurol Neurosurg. 2002 May;104(2):142-5
11932045
Am J Phys Med Rehabil. 1988 Jun;67(3):108-16
3288246
J Neurol Sci. 1974 Nov;23(3):473-84
4154365
Stroke. 2001 Sep;32(9):2099-109
11546903
Clin Neurol Neurosurg. 2005 Jun;107(4):289-95
15885386
Arch Phys Med Rehabil. 2001 Feb;82(2):155-61
11239304
Arch Phys Med Rehabil. 1996 Jan;77(1):35-9
8554471
Top Stroke Rehabil. 2006 Fall;13(4):74-85
17082172
Brain Inj. 2005 May;19(5):359-64
16094783
Arch Phys Med Rehabil. 2006 Nov;87(11):1509-15
17084128
Am J Phys Med Rehabil. 1999 May-Jun;78(3):247-54
10340423
Nurse Pract. 1987 Mar;12(3):27-32
3494216
J Neurol Neurosurg Psychiatry. 2004 Nov;75(11):1553-7
15489386
J Neurosci Nurs. 2004 Dec;36(6):322-7
15673207
Neurosurg Rev. 2002 Aug;25(4):228-30
12172730
J Neurol Neurosurg Psychiatry. 1994 Jul;57(7):773-7
8021658
Paraplegia. 1993 Aug;31(8):516-20
8414636
Arch Phys Med Rehabil. 1999 Jan;80(1):13-9
9915366
Neurosurg Focus. 2006 Aug 15;21(2):e6
16918227
N Engl J Med. 1989 Jun 8;320(23):1517-21
2657424
Neurosurg Focus. 2006 Aug 15;21(2):e5
16918226
Mult Scler. 2006 Feb;12(1):101-3
16459726
Rehabil Nurs. 2006 Jul-Aug;31(4):158-64
16789674
J Neurosurg. 2003 Feb;98(2):291-5
12593613
J Neurosurg. 1993 Feb;78(2):226-32
8421205
Neuromodulation. 2002 Jan;5(1):16-24
22151777